| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/11/2002 | WO2002053017A2 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 07/11/2002 | WO2002052936A1 Preserving agents for freeze-dried cells |
| 07/11/2002 | WO2002052919A2 Methods of searching for solid forms and screening a sample according to its forms |
| 07/11/2002 | WO2002039103A8 Thin film metal hydride hydrogen sensor |
| 07/11/2002 | WO2002039083A3 Fluorescence and fret based assays for biomolecules on beads |
| 07/11/2002 | WO2002038734A3 Methods for determining the biological effects of compounds on gene expression |
| 07/11/2002 | WO2002038731A3 Method for measuring nucleotides |
| 07/11/2002 | WO2002036621A8 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002027315A3 Compounds with a branched linker |
| 07/11/2002 | WO2002027019A8 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 07/11/2002 | WO2002022787A3 Differential treatment of selected parts of a single cell with different fluid components |
| 07/11/2002 | WO2002021130A8 Method and device for simultaneous detection of multiple components in a mixture |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008456A8 Method for identifying metastatic tumor cells |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001094550A3 Identification and use of molecular markers indicating cellular reprogramming |
| 07/11/2002 | WO2001090747A3 Modulation of t-cell receptor interactions |
| 07/11/2002 | WO2001086258A9 Pd/ni-wo3 anodic double layer colormetric gas sensor |
| 07/11/2002 | WO2001084153A3 Diagnostic device with multiple independent flow paths |
| 07/11/2002 | WO2001083781A3 14094, a novel human trypsin family member and uses thereof |
| 07/11/2002 | WO2001081917A3 Chemical signal enhancement of dynamic intensity-based intracellular protein- and fluorophore-based redistribution assays for drug screening |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001057536A3 Method for diagnosis of disease states of the bilio-pancreatic system |
| 07/11/2002 | WO2001054813A8 Devices and methods for biochip multiplexing |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001046383A9 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/11/2002 | WO2001044805A3 Permeation layer attachment chemistry and method |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001038873A3 Devices and methods for detecting analytes using electrosensor having capture reagent |
| 07/11/2002 | WO2001036661A3 Method and apparatus for prokaryotic and eukaryotic cell quantitation |
| 07/11/2002 | WO2001032920A3 Agents implicated in endometriosis |
| 07/11/2002 | WO2001031580A3 Methods and devices for identifying patterns in biological systems |
| 07/11/2002 | WO2001029257A3 Methods of genetic cluster analysis |
| 07/11/2002 | WO2001029054A3 Medicaments for treatment of respiratory syncytial virus infections |
| 07/11/2002 | WO2001028540A3 Agent for treating cephalic pain |
| 07/11/2002 | WO2001024785A3 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 07/11/2002 | WO2001020018A3 Diagnosing and treating arthritic disorders |
| 07/11/2002 | WO2001019981A3 Functional genomics using zinc finger proteins |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001011335A9 Antiviral compounds that inhibit viral replication |
| 07/11/2002 | WO2001011087A3 Method of evaluating a gene transfer vector and gene transfer vector product interactions |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001011035A9 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 07/11/2002 | WO2001007665A9 Sequence determination of nucleic acids using electronic detection |
| 07/11/2002 | WO2001007661A3 Polynucleotide amplification method |
| 07/11/2002 | WO2001006016A9 Amplification of nucleic acids with electronic detection |
| 07/11/2002 | WO2001005837A9 Method for assaying compounds affecting smooth muscle contractile state |
| 07/11/2002 | WO2000078996A9 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 07/11/2002 | WO2000077712A9 Method for assessing significance of protein identification |
| 07/11/2002 | WO2000077486A3 Compositions and methods for detecting treponema pallidum |
| 07/11/2002 | WO2000072834A3 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 07/11/2002 | WO2000068661A9 Detection of cellular exposure to addictive drugs |
| 07/11/2002 | WO2000067024A9 Cancer treatment with endothelin receptor antagonists |
| 07/11/2002 | WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 07/11/2002 | WO2000062067A9 Novel transduction molecules and methods for using same |
| 07/11/2002 | WO2000061816A9 Electronically mediated nucleic acid amplification in nasba |
| 07/11/2002 | WO2000060118A3 Electrophoretic analysis of target molecules using adapter molecules |
| 07/11/2002 | WO2000058730A9 Method and device for detecting analytes in fluids |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 07/11/2002 | WO2000053812A3 Replica amplification of nucleic acid arrays |
| 07/11/2002 | WO2000028982A3 Increasing bone strength with selected bisphosphonates |
| 07/11/2002 | US20020092035 Cell cultures for use in monitoring preferential gene expression in cells |
| 07/11/2002 | US20020092034 Non-human model of gestational and adult folate deficiency and uses thereof |
| 07/11/2002 | US20020091358 Medication delivery device with bended piston rod |
| 07/11/2002 | US20020091250 Metabotropic GABA [B] receptors, receptor-specific ligands and their uses |
| 07/11/2002 | US20020091245 Process for immobilization of nucleic acid molecules on a substrate |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091086 Peptides that block viral infectivity and methods of use thereof |
| 07/11/2002 | US20020091085 Src SH3 binding peptides and methods of isolating and using same |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020091073 Method to limit immunodeficiency virus infection and compounds therefor |
| 07/11/2002 | US20020091072 Endothelin converting enzymes and the amyloid beta peptide |
| 07/11/2002 | US20020090740 Method and apparatus for performing an assay |
| 07/11/2002 | US20020090738 System and method of microdispensing and arrays of biolayers provided by same |
| 07/11/2002 | US20020090735 Protection of semiconductor fabrication and similar sensitive processes |
| 07/11/2002 | US20020090734 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
| 07/11/2002 | US20020090732 Modulator for use in the treatment of brain, psychological and nervous system disorders |
| 07/11/2002 | US20020090728 High-throughput screening for the detection of preferential reaction products; obtain sample, monitor enantiomeric ratios, absolute configuration and percent conversion for preferential products |
| 07/11/2002 | US20020090727 Determination of heteroatom content in fischer-tropsch wax |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090676 TNF receptors, TNF binding proteins and DNAs coding for them |
| 07/11/2002 | US20020090673 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090672 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090671 Bone stimulating factor |
| 07/11/2002 | US20020090667 Detection of Helicobacter Pylori |
| 07/11/2002 | US20020090665 High throughput screening assay systems in microscale fluidic devices |
| 07/11/2002 | US20020090664 Monitoring stress in humans; measure activity of hypothalamus-pituitary-adrenal system of human, compare to control, evaluate stress |
| 07/11/2002 | US20020090663 Immunoassay for fish identification |
| 07/11/2002 | US20020090662 Analytical method |
| 07/11/2002 | US20020090661 Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples |
| 07/11/2002 | US20020090660 Helicobacter pylori antigens in blood |
| 07/11/2002 | US20020090659 Detection and visualization of neoplastic tissues and other tissues |